A critical advance in cancer research is arising with the use of mini-antibodies to re-engage dysfunctional p53. This crucial cancer protector protein is frequently lost in many types of malignancies, resulting https://bookmarkspring.com/story17159702/nanobodies-restore-tumor-suppressor-p53-the-new-approach-for-tumor-management